ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1459

Bone Erosion Volume Changes Measured By HR-pQCT at 3-Months after Initiation of Anti-TNF Treatment Predicted Erosion Volume Changes at 1-Year in RA

Tomohiro Shimizu1, Kenji Mamoto1, Matthew Tanaka1, Andrew J Burghardt2, Thomas Link1, Jonathan Graf3, John B. Imboden Jr.3 and Xiaojuan Li1, 1Radiology and Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, University of California, San Francisco, San Francisco, CA, 2Department of Radiology & Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, University of California, San Francisco, San Francisco, CA, 3Medicine, University of California, San Francisco, San Francisco, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: HR-pQCT, Imaging and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Bone erosions and joint space narrowing (JSN) are significant aspects of structural damage in rheumatoid arthritis. High resolution peripheral quantitative computed tomography (HR-pQCT) allows detailed analysis of bone erosion, joint space and bone microstructure. We previously reported bone erosion and microarchitecture evaluation using HR-pQCT within the first three months after the initiation of anti-tumor necrosis factor (TNFα) treatment. However, no study has yet reported if early bone changes such as three months would predict the future changes of bone destruction. Hence, the goal of this study was to quantify erosion volume, bone microarchitecture, joint space volume and width from prior to anti-TNFα therapy to one year after initiation using HR-pQCT, and to investigate if development of erosions at 3-months can predict progression of erosions after 1 year.

Methods: Twenty-one RA patients receiving MTX treatment were recruited and divided into two groups according to disease activity scores (low (DAS28≦3.2) (N=9) and high (DAS28>3.2) (N=12) DAS group). Patients in the high DAS group were treated with anti-TNFα and MTX immediately after the baseline MRI (BL). All patients underwent HR-pQCT scans of the MCP at BL, 3-months (3M) and 1-year (1Y). HR-pQCT-derived erosion volume, joint space volume and width and bone microarchitecture at the MCP2 and MCP3 were measured using in-house developed software with previously reported excellent in-vivo reproducibility.

Results: 37 bone erosions were detected at BL. In the high DAS group, one erosion was full repaired, while two new erosions were observed at 1-year. Although there were no significant changes of mean bone erosion volume in the high DAS group from BL to 1Y, the low DAS group showed increases in mean bone erosion volume from BL to 1Y regardless of lower disease activity (P=0.006). Changes of bone erosion volume from BL to 3M were significantly correlated with changes of bone erosion volume from 3M to 1Y (P=0.001). On the other hand, both groups showed significant joint space narrowing at 1Y compared to BL (P=0.008).

Conclusion: Our findings suggest that early changes in bone erosion volume can predict future disease progression. Therefore, additional treatment may be necessary for patients whose bone erosion volume increases during the early period despite good response for DAS28. HR-pQCT provides sensitive technique to measure erosion progression even within 3-months after treatment.


Disclosure: T. Shimizu, None; K. Mamoto, None; M. Tanaka, None; A. J. Burghardt, None; T. Link, None; J. Graf, None; J. B. Imboden Jr., None; X. Li, None.

To cite this abstract in AMA style:

Shimizu T, Mamoto K, Tanaka M, Burghardt AJ, Link T, Graf J, Imboden JB Jr., Li X. Bone Erosion Volume Changes Measured By HR-pQCT at 3-Months after Initiation of Anti-TNF Treatment Predicted Erosion Volume Changes at 1-Year in RA [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/bone-erosion-volume-changes-measured-by-hr-pqct-at-3-months-after-initiation-of-anti-tnf-treatment-predicted-erosion-volume-changes-at-1-year-in-ra/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-erosion-volume-changes-measured-by-hr-pqct-at-3-months-after-initiation-of-anti-tnf-treatment-predicted-erosion-volume-changes-at-1-year-in-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology